| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 1.27e-05 | 46 | 20 | 3 | GO:0005245 | |
| GeneOntologyMolecularFunction | calcium channel activity | 2.77e-04 | 129 | 20 | 3 | GO:0005262 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 4.40e-04 | 151 | 20 | 3 | GO:0015085 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | 4.48e-04 | 152 | 20 | 3 | GO:0022843 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | 7.50e-04 | 758 | 20 | 5 | GO:0015318 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 7.57e-04 | 182 | 20 | 3 | GO:0005244 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 7.82e-04 | 184 | 20 | 3 | GO:0022832 | |
| GeneOntologyMolecularFunction | ionotropic glutamate receptor binding | 1.23e-03 | 52 | 20 | 2 | GO:0035255 | |
| GeneOntologyMolecularFunction | protein domain specific binding | 1.43e-03 | 875 | 20 | 5 | GO:0019904 | |
| GeneOntologyMolecularFunction | glutamate receptor binding | 2.94e-03 | 81 | 20 | 2 | GO:0035254 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | 3.12e-03 | 627 | 20 | 4 | GO:0022890 | |
| GeneOntologyMolecularFunction | gated channel activity | 4.28e-03 | 334 | 20 | 3 | GO:0022836 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 4.61e-03 | 343 | 20 | 3 | GO:0005261 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | 5.26e-03 | 1180 | 20 | 5 | GO:0022857 | |
| GeneOntologyMolecularFunction | PDZ domain binding | 6.65e-03 | 123 | 20 | 2 | GO:0030165 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | 7.19e-03 | 793 | 20 | 4 | GO:0015075 | |
| GeneOntologyMolecularFunction | transporter activity | 7.63e-03 | 1289 | 20 | 5 | GO:0005215 | |
| GeneOntologyBiologicalProcess | mRNA splicing, via spliceosome | 1.92e-05 | 358 | 20 | 5 | GO:0000398 | |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 1.92e-05 | 358 | 20 | 5 | GO:0000377 | |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions | 2.02e-05 | 362 | 20 | 5 | GO:0000375 | |
| GeneOntologyBiologicalProcess | neurotransmitter receptor transport, postsynaptic endosome to lysosome | 2.49e-05 | 8 | 20 | 2 | GO:0098943 | |
| GeneOntologyBiologicalProcess | positive regulation of synapse maturation | 4.00e-05 | 10 | 20 | 2 | GO:0090129 | |
| GeneOntologyBiologicalProcess | postsynaptic neurotransmitter receptor diffusion trapping | 6.92e-05 | 13 | 20 | 2 | GO:0098970 | |
| GeneOntologyBiologicalProcess | neurotransmitter receptor diffusion trapping | 6.92e-05 | 13 | 20 | 2 | GO:0099628 | |
| GeneOntologyBiologicalProcess | receptor diffusion trapping | 8.07e-05 | 14 | 20 | 2 | GO:0098953 | |
| GeneOntologyBiologicalProcess | RNA splicing | 9.59e-05 | 502 | 20 | 5 | GO:0008380 | |
| GeneOntologyBiologicalProcess | mRNA processing | 1.48e-04 | 551 | 20 | 5 | GO:0006397 | |
| GeneOntologyBiologicalProcess | transmission of nerve impulse | 1.66e-04 | 112 | 20 | 3 | GO:0019226 | |
| GeneOntologyBiologicalProcess | mRNA metabolic process | 1.72e-04 | 917 | 20 | 6 | GO:0016071 | |
| GeneOntologyBiologicalProcess | regulation of mRNA splicing, via spliceosome | 2.52e-04 | 129 | 20 | 3 | GO:0048024 | |
| GeneOntologyBiologicalProcess | regulation of AMPA receptor activity | 2.64e-04 | 25 | 20 | 2 | GO:2000311 | |
| GeneOntologyBiologicalProcess | regulation of synapse maturation | 4.08e-04 | 31 | 20 | 2 | GO:0090128 | |
| GeneOntologyBiologicalProcess | regulation of mRNA processing | 4.57e-04 | 158 | 20 | 3 | GO:0050684 | |
| GeneOntologyBiologicalProcess | protein localization to cell periphery | 6.45e-04 | 422 | 20 | 4 | GO:1990778 | |
| GeneOntologyBiologicalProcess | neurotransmitter receptor transport | 7.51e-04 | 42 | 20 | 2 | GO:0099637 | |
| GeneOntologyBiologicalProcess | regulation of mRNA metabolic process | 7.74e-04 | 443 | 20 | 4 | GO:1903311 | |
| GeneOntologyBiologicalProcess | positive regulation of synaptic transmission, glutamatergic | 7.88e-04 | 43 | 20 | 2 | GO:0051968 | |
| GeneOntologyBiologicalProcess | positive regulation of mRNA splicing, via spliceosome | 8.25e-04 | 44 | 20 | 2 | GO:0048026 | |
| GeneOntologyBiologicalProcess | regulation of RNA splicing | 1.00e-03 | 207 | 20 | 3 | GO:0043484 | |
| GeneOntologyBiologicalProcess | neurotransmitter receptor localization to postsynaptic specialization membrane | 1.02e-03 | 49 | 20 | 2 | GO:0099645 | |
| GeneOntologyBiologicalProcess | protein localization to postsynaptic specialization membrane | 1.02e-03 | 49 | 20 | 2 | GO:0099633 | |
| GeneOntologyBiologicalProcess | positive regulation of mRNA processing | 1.02e-03 | 49 | 20 | 2 | GO:0050685 | |
| GeneOntologyBiologicalProcess | synapse maturation | 1.06e-03 | 50 | 20 | 2 | GO:0060074 | |
| GeneOntologyBiologicalProcess | regulation of neurotransmitter receptor activity | 1.33e-03 | 56 | 20 | 2 | GO:0099601 | |
| GeneOntologyBiologicalProcess | neurotransmitter receptor internalization | 1.43e-03 | 58 | 20 | 2 | GO:0099590 | |
| GeneOntologyBiologicalProcess | protein localization to lysosome | 1.53e-03 | 60 | 20 | 2 | GO:0061462 | |
| GeneOntologyCellularComponent | voltage-gated calcium channel complex | 1.11e-05 | 46 | 20 | 3 | GO:0005891 | |
| GeneOntologyCellularComponent | cerebellar mossy fiber | 3.12e-05 | 9 | 20 | 2 | GO:0044300 | |
| GeneOntologyCellularComponent | calcium channel complex | 4.46e-05 | 73 | 20 | 3 | GO:0034704 | |
| GeneOntologyCellularComponent | AMPA glutamate receptor complex | 3.72e-04 | 30 | 20 | 2 | GO:0032281 | |
| GeneOntologyCellularComponent | ionotropic glutamate receptor complex | 8.40e-04 | 45 | 20 | 2 | GO:0008328 | |
| GeneOntologyCellularComponent | neurotransmitter receptor complex | 1.04e-03 | 50 | 20 | 2 | GO:0098878 | |
| GeneOntologyCellularComponent | transmembrane transporter complex | 1.36e-03 | 523 | 20 | 4 | GO:1902495 | |
| GeneOntologyCellularComponent | cation channel complex | 1.39e-03 | 235 | 20 | 3 | GO:0034703 | |
| GeneOntologyCellularComponent | nuclear inner membrane | 1.44e-03 | 59 | 20 | 2 | GO:0005637 | |
| GeneOntologyCellularComponent | transporter complex | 1.64e-03 | 550 | 20 | 4 | GO:1990351 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 5.32e-03 | 378 | 20 | 3 | GO:0034702 | |
| GeneOntologyCellularComponent | endocytic vesicle | 5.56e-03 | 384 | 20 | 3 | GO:0030139 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | 5.91e-03 | 785 | 20 | 4 | GO:0098797 | |
| GeneOntologyCellularComponent | postsynaptic membrane | 6.44e-03 | 405 | 20 | 3 | GO:0045211 | |
| HumanPheno | Portal vein thrombosis | 6.33e-05 | 11 | 6 | 2 | HP:0030242 | |
| HumanPheno | Abnormal portal venous system morphology | 8.97e-05 | 13 | 6 | 2 | HP:0031941 | |
| Domain | VDCC_gsu | 2.74e-05 | 8 | 19 | 2 | IPR008368 | |
| Domain | RRM_1 | 5.08e-05 | 208 | 19 | 4 | PF00076 | |
| Domain | RRM | 5.99e-05 | 217 | 19 | 4 | SM00360 | |
| Domain | RRM_dom | 7.14e-05 | 227 | 19 | 4 | IPR000504 | |
| Domain | RRM | 7.51e-05 | 230 | 19 | 4 | PS50102 | |
| Domain | - | 9.44e-05 | 244 | 19 | 4 | 3.30.70.330 | |
| Domain | Nucleotide-bd_a/b_plait | 1.17e-04 | 258 | 19 | 4 | IPR012677 | |
| Domain | Claudin | 3.65e-04 | 28 | 19 | 2 | IPR006187 | |
| Domain | PMP22_Claudin | 7.47e-04 | 40 | 19 | 2 | PF00822 | |
| Domain | PMP22/EMP/MP20/Claudin | 9.46e-04 | 45 | 19 | 2 | IPR004031 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_ENTRY_VOLTAGE_GATED_CA2_CHANNEL | 3.30e-06 | 25 | 17 | 3 | M47948 | |
| Pathway | KEGG_CARDIAC_MUSCLE_CONTRACTION | 1.09e-04 | 79 | 17 | 3 | M17673 | |
| Pathway | REACTOME_LGI_ADAM_INTERACTIONS | 1.24e-04 | 14 | 17 | 2 | MM15277 | |
| Pathway | REACTOME_LGI_ADAM_INTERACTIONS | 1.24e-04 | 14 | 17 | 2 | M27564 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CARDIAC_TYPE_VGCC_RYR_SIGNALING | 2.84e-04 | 21 | 17 | 2 | M47950 | |
| Pathway | KEGG_MEDICUS_REFERENCE_SKELETAL_TYPE_VGCC_RYR_SIGNALING | 2.84e-04 | 21 | 17 | 2 | M47949 | |
| Pathway | KEGG_SPLICEOSOME | 4.43e-04 | 127 | 17 | 3 | M2044 | |
| Pathway | REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS | 5.45e-04 | 29 | 17 | 2 | MM15028 | |
| Pathway | REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS | 6.24e-04 | 31 | 17 | 2 | M7223 | |
| Pathway | REACTOME_MRNA_SPLICING | 1.95e-03 | 212 | 17 | 3 | M14033 | |
| Pubmed | The protein interaction landscape of the human CMGC kinase group. | 6.66e-11 | 695 | 20 | 9 | 23602568 | |
| Pubmed | The cellular EJC interactome reveals higher-order mRNP structure and an EJC-SR protein nexus. | 3.73e-08 | 169 | 20 | 5 | 23084401 | |
| Pubmed | TARP redundancy is critical for maintaining AMPA receptor function. | 3.14e-07 | 2 | 20 | 2 | 18753375 | |
| Pubmed | 3.14e-07 | 2 | 20 | 2 | 10221464 | ||
| Pubmed | Human Tra2 proteins are sequence-specific activators of pre-mRNA splicing. | 3.14e-07 | 2 | 20 | 2 | 9546399 | |
| Pubmed | TARPs differentially decorate AMPA receptors to specify neuropharmacology. | 3.14e-07 | 2 | 20 | 2 | 20219255 | |
| Pubmed | Differential Effects of Tra2ß Isoforms on HIV-1 RNA Processing and Expression. | 3.14e-07 | 2 | 20 | 2 | 25970345 | |
| Pubmed | 3.18e-07 | 260 | 20 | 5 | 36199071 | ||
| Pubmed | ATRX promotes heterochromatin formation to protect cells from G-quadruplex DNA-mediated stress. | 4.19e-07 | 26 | 20 | 3 | 34162889 | |
| Pubmed | 9.42e-07 | 3 | 20 | 2 | 14505496 | ||
| Pubmed | A targeted mutation in Cacng4 exacerbates spike-wave seizures in stargazer (Cacng2) mice. | 9.42e-07 | 3 | 20 | 2 | 15677329 | |
| Pubmed | 9.42e-07 | 3 | 20 | 2 | 22194695 | ||
| Pubmed | Tra2-mediated recognition of HIV-1 5' splice site D3 as a key factor in the processing of vpr mRNA. | 9.42e-07 | 3 | 20 | 2 | 23255807 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 1.60e-06 | 361 | 20 | 5 | 26167880 | |
| Pubmed | 1.65e-06 | 153 | 20 | 4 | 28225217 | ||
| Pubmed | Functional modulation of AMPA receptors by transmembrane AMPA receptor regulatory proteins. | 1.88e-06 | 4 | 20 | 2 | 18304745 | |
| Pubmed | Critical role for TARPs in early development despite broad functional redundancy. | 1.88e-06 | 4 | 20 | 2 | 18634809 | |
| Pubmed | Dephosphorylated SRp38 acts as a splicing repressor in response to heat shock. | 1.88e-06 | 4 | 20 | 2 | 14765198 | |
| Pubmed | 3.14e-06 | 5 | 20 | 2 | 28785060 | ||
| Pubmed | Conserved expression of ultra-conserved noncoding RNA in mammalian nervous system. | 5.45e-06 | 60 | 20 | 3 | 29055695 | |
| Pubmed | 6.59e-06 | 7 | 20 | 2 | 27076426 | ||
| Pubmed | Calcium channel gamma subunits: a functionally diverse protein family. | 8.78e-06 | 8 | 20 | 2 | 17652770 | |
| Pubmed | 1.05e-05 | 244 | 20 | 4 | 29884807 | ||
| Pubmed | 1.13e-05 | 9 | 20 | 2 | 11170751 | ||
| Pubmed | Accumulation of AMPA receptors in autophagosomes in neuronal axons lacking adaptor protein AP-4. | 1.72e-05 | 11 | 20 | 2 | 18341993 | |
| Pubmed | 2.69e-05 | 102 | 20 | 3 | 11214970 | ||
| Pubmed | ATAC and Mediator coactivators form a stable complex and regulate a set of non-coding RNA genes. | 3.11e-05 | 107 | 20 | 3 | 20508642 | |
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | 3.19e-05 | 670 | 20 | 5 | 22990118 | |
| Pubmed | ZBTB2 protein is a new partner of the Nucleosome Remodeling and Deacetylase (NuRD) complex. | 3.42e-05 | 330 | 20 | 4 | 33301849 | |
| Pubmed | 3.75e-05 | 16 | 20 | 2 | 24586484 | ||
| Pubmed | 4.29e-05 | 713 | 20 | 5 | 29802200 | ||
| Pubmed | 4.83e-05 | 731 | 20 | 5 | 29298432 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | 6.49e-05 | 1294 | 20 | 6 | 30804502 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | 7.71e-05 | 807 | 20 | 5 | 22681889 | |
| Pubmed | 8.61e-05 | 24 | 20 | 2 | 22632720 | ||
| Pubmed | 8.79e-05 | 421 | 20 | 4 | 34650049 | ||
| Pubmed | TRIM28-mediated nucleocapsid protein SUMOylation enhances SARS-CoV-2 virulence. | 9.54e-05 | 430 | 20 | 4 | 38172120 | |
| Pubmed | 1.05e-04 | 441 | 20 | 4 | 31239290 | ||
| Pubmed | 1.63e-04 | 187 | 20 | 3 | 26460568 | ||
| Pubmed | 1.66e-04 | 188 | 20 | 3 | 29721183 | ||
| Pubmed | 1.74e-04 | 503 | 20 | 4 | 16964243 | ||
| Pubmed | Dynamic protein-protein interaction wiring of the human spliceosome. | 1.90e-04 | 197 | 20 | 3 | 22365833 | |
| Pubmed | 1.90e-04 | 197 | 20 | 3 | 36604605 | ||
| Pubmed | Ion channel expression in the developing enteric nervous system. | 2.07e-04 | 37 | 20 | 2 | 25798587 | |
| Pubmed | 2.08e-04 | 203 | 20 | 3 | 35012549 | ||
| Pubmed | 2.74e-04 | 223 | 20 | 3 | 33731348 | ||
| Pubmed | 3.84e-04 | 1139 | 20 | 5 | 36417873 | ||
| Pubmed | 3.87e-04 | 251 | 20 | 3 | 31076518 | ||
| Pubmed | A Compendium of RNA-Binding Proteins that Regulate MicroRNA Biogenesis. | 4.00e-04 | 254 | 20 | 3 | 28431233 | |
| Pubmed | SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9. | 4.19e-04 | 258 | 20 | 3 | 37794589 | |
| Pubmed | Regulation of alternative splicing by SRrp86 and its interacting proteins. | 4.92e-04 | 57 | 20 | 2 | 14559993 | |
| Pubmed | 5.27e-04 | 59 | 20 | 2 | 31551363 | ||
| Interaction | SRPK2 interactions | 1.03e-08 | 717 | 20 | 9 | int:SRPK2 | |
| Interaction | CLK2 interactions | 2.63e-08 | 195 | 20 | 6 | int:CLK2 | |
| Interaction | SAP18 interactions | 3.71e-07 | 305 | 20 | 6 | int:SAP18 | |
| Interaction | CLK3 interactions | 2.01e-06 | 220 | 20 | 5 | int:CLK3 | |
| Interaction | MAGOH interactions | 4.90e-06 | 264 | 20 | 5 | int:MAGOH | |
| Interaction | SNRPA interactions | 5.29e-06 | 482 | 20 | 6 | int:SNRPA | |
| Interaction | SRSF6 interactions | 6.75e-06 | 503 | 20 | 6 | int:SRSF6 | |
| Interaction | HNRNPUL2 interactions | 7.87e-06 | 291 | 20 | 5 | int:HNRNPUL2 | |
| Interaction | PABPC5 interactions | 1.05e-05 | 142 | 20 | 4 | int:PABPC5 | |
| Interaction | NKAPD1 interactions | 1.72e-05 | 161 | 20 | 4 | int:NKAPD1 | |
| Interaction | ELAVL2 interactions | 3.16e-05 | 188 | 20 | 4 | int:ELAVL2 | |
| Interaction | MIR138-1 interactions | 4.02e-05 | 68 | 20 | 3 | int:MIR138-1 | |
| Interaction | MIR29B2 interactions | 4.58e-05 | 71 | 20 | 3 | int:MIR29B2 | |
| Interaction | MIR140 interactions | 4.58e-05 | 71 | 20 | 3 | int:MIR140 | |
| Interaction | MIR122 interactions | 4.58e-05 | 71 | 20 | 3 | int:MIR122 | |
| Interaction | SRSF7 interactions | 4.86e-05 | 425 | 20 | 5 | int:SRSF7 | |
| Interaction | MIR29B1 interactions | 4.97e-05 | 73 | 20 | 3 | int:MIR29B1 | |
| Interaction | MIR18A interactions | 4.97e-05 | 73 | 20 | 3 | int:MIR18A | |
| Interaction | MIR20A interactions | 5.18e-05 | 74 | 20 | 3 | int:MIR20A | |
| Interaction | MIR15A interactions | 5.39e-05 | 75 | 20 | 3 | int:MIR15A | |
| Interaction | MIR16-1 interactions | 5.61e-05 | 76 | 20 | 3 | int:MIR16-1 | |
| Interaction | MIR199A2 interactions | 5.61e-05 | 76 | 20 | 3 | int:MIR199A2 | |
| Interaction | MIR429 interactions | 5.61e-05 | 76 | 20 | 3 | int:MIR429 | |
| Interaction | MIR7-3 interactions | 5.61e-05 | 76 | 20 | 3 | int:MIR7-3 | |
| Interaction | CLK1 interactions | 5.73e-05 | 219 | 20 | 4 | int:CLK1 | |
| Interaction | SNRPC interactions | 5.73e-05 | 440 | 20 | 5 | int:SNRPC | |
| Interaction | MIR9-2 interactions | 5.83e-05 | 77 | 20 | 3 | int:MIR9-2 | |
| Interaction | MIR92A1 interactions | 6.06e-05 | 78 | 20 | 3 | int:MIR92A1 | |
| Interaction | MIR451A interactions | 6.06e-05 | 78 | 20 | 3 | int:MIR451A | |
| Interaction | MIR98 interactions | 6.06e-05 | 78 | 20 | 3 | int:MIR98 | |
| Interaction | SRSF9 interactions | 6.26e-05 | 224 | 20 | 4 | int:SRSF9 | |
| Interaction | MIR222 interactions | 6.30e-05 | 79 | 20 | 3 | int:MIR222 | |
| Interaction | MIR206 interactions | 6.30e-05 | 79 | 20 | 3 | int:MIR206 | |
| Interaction | MIR1-2 interactions | 6.30e-05 | 79 | 20 | 3 | int:MIR1-2 | |
| Interaction | MIR34C interactions | 6.30e-05 | 79 | 20 | 3 | int:MIR34C | |
| Interaction | MIR143 interactions | 6.54e-05 | 80 | 20 | 3 | int:MIR143 | |
| Interaction | MIR145 interactions | 6.79e-05 | 81 | 20 | 3 | int:MIR145 | |
| Interaction | MRS2 interactions | 7.30e-05 | 83 | 20 | 3 | int:MRS2 | |
| Interaction | MIR31 interactions | 7.57e-05 | 84 | 20 | 3 | int:MIR31 | |
| Interaction | MIR199A1 interactions | 7.57e-05 | 84 | 20 | 3 | int:MIR199A1 | |
| Interaction | MIR200B interactions | 7.57e-05 | 84 | 20 | 3 | int:MIR200B | |
| Interaction | MIR7-2 interactions | 7.57e-05 | 84 | 20 | 3 | int:MIR7-2 | |
| Interaction | MIR16-2 interactions | 7.84e-05 | 85 | 20 | 3 | int:MIR16-2 | |
| Interaction | MIR107 interactions | 7.84e-05 | 85 | 20 | 3 | int:MIR107 | |
| Interaction | MIR17 interactions | 7.84e-05 | 85 | 20 | 3 | int:MIR17 | |
| Interaction | MIR93 interactions | 7.84e-05 | 85 | 20 | 3 | int:MIR93 | |
| Interaction | MIR9-1 interactions | 7.84e-05 | 85 | 20 | 3 | int:MIR9-1 | |
| Interaction | GRIA1 interactions | 8.12e-05 | 86 | 20 | 3 | int:GRIA1 | |
| Interaction | MIR20B interactions | 8.12e-05 | 86 | 20 | 3 | int:MIR20B | |
| Interaction | SRPK1 interactions | 8.40e-05 | 477 | 20 | 5 | int:SRPK1 | |
| Interaction | MIR138-2 interactions | 8.69e-05 | 88 | 20 | 3 | int:MIR138-2 | |
| Interaction | MIR29C interactions | 8.99e-05 | 89 | 20 | 3 | int:MIR29C | |
| Interaction | MIR221 interactions | 9.29e-05 | 90 | 20 | 3 | int:MIR221 | |
| Interaction | MIR1-1 interactions | 9.29e-05 | 90 | 20 | 3 | int:MIR1-1 | |
| Interaction | MIR200C interactions | 9.60e-05 | 91 | 20 | 3 | int:MIR200C | |
| Interaction | MIR155 interactions | 9.92e-05 | 92 | 20 | 3 | int:MIR155 | |
| Interaction | MIR128-1 interactions | 9.92e-05 | 92 | 20 | 3 | int:MIR128-1 | |
| Interaction | MIR214 interactions | 1.02e-04 | 93 | 20 | 3 | int:MIR214 | |
| Interaction | MIR205 interactions | 1.02e-04 | 93 | 20 | 3 | int:MIR205 | |
| Interaction | MIRLET7F1 interactions | 1.06e-04 | 94 | 20 | 3 | int:MIRLET7F1 | |
| Interaction | MIRLET7A2 interactions | 1.13e-04 | 96 | 20 | 3 | int:MIRLET7A2 | |
| Interaction | MIRLET7C interactions | 1.16e-04 | 97 | 20 | 3 | int:MIRLET7C | |
| Interaction | MIR21 interactions | 1.16e-04 | 97 | 20 | 3 | int:MIR21 | |
| Interaction | MIR363 interactions | 1.16e-04 | 97 | 20 | 3 | int:MIR363 | |
| Interaction | SRSF8 interactions | 1.20e-04 | 98 | 20 | 3 | int:SRSF8 | |
| Interaction | MIR106B interactions | 1.20e-04 | 98 | 20 | 3 | int:MIR106B | |
| Interaction | MIR128-2 interactions | 1.23e-04 | 99 | 20 | 3 | int:MIR128-2 | |
| Interaction | ATRX interactions | 1.23e-04 | 267 | 20 | 4 | int:ATRX | |
| Interaction | MIR19A interactions | 1.27e-04 | 100 | 20 | 3 | int:MIR19A | |
| Interaction | SRSF3 interactions | 1.28e-04 | 522 | 20 | 5 | int:SRSF3 | |
| Interaction | MIRLET7B interactions | 1.31e-04 | 101 | 20 | 3 | int:MIRLET7B | |
| Interaction | MIRLET7D interactions | 1.31e-04 | 101 | 20 | 3 | int:MIRLET7D | |
| Interaction | MIR25 interactions | 1.31e-04 | 101 | 20 | 3 | int:MIR25 | |
| Interaction | CPSF6 interactions | 1.33e-04 | 526 | 20 | 5 | int:CPSF6 | |
| Interaction | MIRLET7A3 interactions | 1.35e-04 | 102 | 20 | 3 | int:MIRLET7A3 | |
| Interaction | MIR15B interactions | 1.39e-04 | 103 | 20 | 3 | int:MIR15B | |
| Interaction | MIR7-1 interactions | 1.39e-04 | 103 | 20 | 3 | int:MIR7-1 | |
| Interaction | MIR34A interactions | 1.43e-04 | 104 | 20 | 3 | int:MIR34A | |
| Interaction | MIR19B1 interactions | 1.43e-04 | 104 | 20 | 3 | int:MIR19B1 | |
| Interaction | MIRLET7E interactions | 1.51e-04 | 106 | 20 | 3 | int:MIRLET7E | |
| Interaction | GSPT2 interactions | 1.55e-04 | 107 | 20 | 3 | int:GSPT2 | |
| Interaction | MIRLET7A1 interactions | 1.60e-04 | 108 | 20 | 3 | int:MIRLET7A1 | |
| Interaction | MIR34B interactions | 1.69e-04 | 110 | 20 | 3 | int:MIR34B | |
| Interaction | MIRLET7I interactions | 1.87e-04 | 114 | 20 | 3 | int:MIRLET7I | |
| Interaction | SRSF4 interactions | 1.93e-04 | 300 | 20 | 4 | int:SRSF4 | |
| Interaction | ZNF514 interactions | 1.94e-04 | 21 | 20 | 2 | int:ZNF514 | |
| Interaction | BUD31 interactions | 1.97e-04 | 116 | 20 | 3 | int:BUD31 | |
| Interaction | MIRLET7G interactions | 2.02e-04 | 117 | 20 | 3 | int:MIRLET7G | |
| Interaction | TRA2A interactions | 2.78e-04 | 330 | 20 | 4 | int:TRA2A | |
| Interaction | SRRM1 interactions | 3.40e-04 | 348 | 20 | 4 | int:SRRM1 | |
| Interaction | SUZ12 interactions | 3.41e-04 | 644 | 20 | 5 | int:SUZ12 | |
| Interaction | U2AF2 interactions | 3.59e-04 | 651 | 20 | 5 | int:U2AF2 | |
| Interaction | LUC7L2 interactions | 3.59e-04 | 353 | 20 | 4 | int:LUC7L2 | |
| Interaction | RALY interactions | 3.71e-04 | 356 | 20 | 4 | int:RALY | |
| Interaction | APOBEC3D interactions | 4.04e-04 | 148 | 20 | 3 | int:APOBEC3D | |
| Interaction | YARS1 interactions | 4.12e-04 | 149 | 20 | 3 | int:YARS1 | |
| Interaction | SSRP1 interactions | 4.53e-04 | 685 | 20 | 5 | int:SSRP1 | |
| Interaction | MAGOHB interactions | 4.62e-04 | 155 | 20 | 3 | int:MAGOHB | |
| Interaction | TRA2B interactions | 4.99e-04 | 385 | 20 | 4 | int:TRA2B | |
| Interaction | PHAX interactions | 5.74e-04 | 167 | 20 | 3 | int:PHAX | |
| GeneFamily | Calcium voltage-gated channel subunits | 1.46e-06 | 26 | 16 | 3 | 253 | |
| GeneFamily | RNA binding motif containing | 8.06e-04 | 213 | 16 | 3 | 725 | |
| Coexpression | GSE1925_CTRL_VS_3H_IFNG_STIM_IFNG_PRIMED_MACROPHAGE_DN | 1.45e-05 | 200 | 20 | 4 | M6310 | |
| ToppCell | ILEUM-inflamed-(1)_T_cell-(1)_CD8_Trm|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.25e-06 | 184 | 20 | 4 | cef3ee2a4a0af961aa3b4c92150d423e841ae8c1 | |
| ToppCell | (00)_Basal-(4)_1wkpi|(00)_Basal / shred by cell type and Timepoint | 1.27e-06 | 185 | 20 | 4 | bf82ba905e5eee1c39a2731702071d3de10a78b8 | |
| ToppCell | ILEUM-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.33e-06 | 187 | 20 | 4 | 0099def970fbc828756fbf853eca2ce77b8cd342 | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_B|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.67e-06 | 198 | 20 | 4 | 5f465cf5c7493e32d9afe9e9d05757d0a95acc33 | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_B-B_lineage|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.67e-06 | 198 | 20 | 4 | 77ce3fe1ab161c0faf8987e73a64ab61294b9255 | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_B0|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.10e-05 | 138 | 20 | 3 | 2709fb83dfe6c2e27050b08b678a6d6b25d47906 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.44e-05 | 143 | 20 | 3 | 5fb5a4ea93e5cce55d427e3b4a50a979504fad3c | |
| ToppCell | Mild/Remission-B_naive-4|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.82e-05 | 148 | 20 | 3 | dd5e1bc02824e743e1c030a303e32f27a359a8ca | |
| ToppCell | facs-Marrow-Granulocytes-18m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.90e-05 | 161 | 20 | 3 | 60f433eab9d5531bdf6aa86b0265f20b866b904c | |
| ToppCell | Control-Lymphocyte-T_NK-MAIT|Control / Disease, Lineage and Cell Type | 5.66e-05 | 169 | 20 | 3 | 8c2aac193a9c500f01a99a2ee530839c851b6222 | |
| ToppCell | droplet-Marrow-BM-30m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.66e-05 | 169 | 20 | 3 | 8e7a30eb546fc6fa184ebb76f54b74b278005a84 | |
| ToppCell | Severe-B_activate-7|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 5.86e-05 | 171 | 20 | 3 | 61205a4986c2d0a89aea96ed8dec9e952eeb6ff1 | |
| ToppCell | facs-GAT-Fat-18m-Endothelial-endothelial_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.72e-05 | 179 | 20 | 3 | e0542694fa79d67f67be6f85b4fa6d18f7523253 | |
| ToppCell | facs-GAT-Fat-18m-Endothelial-nan|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.72e-05 | 179 | 20 | 3 | 83343b68977969c7978acd930a66fc7c44df6a15 | |
| ToppCell | facs-GAT-Fat-18m-Endothelial|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.72e-05 | 179 | 20 | 3 | d56fa2a0b119d51a8d41b00fbbd7dfddefeb279c | |
| ToppCell | ILEUM-non-inflamed-(1)_T_cell-(1)_CD8_Trm|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 7.89e-05 | 189 | 20 | 3 | 2c8a2fb76ea002bac554bc1c761ce960b5e116e1 | |
| ToppCell | Severe-B_activate-7|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 8.02e-05 | 190 | 20 | 3 | 67e6c8a5a8724bdf2861fd76a711319dfc71d47a | |
| ToppCell | metastatic_Brain-T/NK_cells-Exhausted_CD8+_T|T/NK_cells / Location, Cell class and cell subclass | 8.14e-05 | 191 | 20 | 3 | 2ffd40ebf1d63e61a97208ddcbeb6a86e409f9d8 | |
| ToppCell | COVID-19_Convalescent-PLT_4|COVID-19_Convalescent / Disease Group and Platelet Clusters | 8.53e-05 | 194 | 20 | 3 | ce1fad4e76a87f0c35e430ed1f2262395df882fd | |
| ToppCell | 10x3'2.3|World / cell types per 3 fetal stages;per 3',per 5' | 8.53e-05 | 194 | 20 | 3 | fc7ed8350ffe1475b8934dfbb107b51991876b0b | |
| ToppCell | COVID-19_Severe-PLT_4|World / Disease Group and Platelet Clusters | 8.79e-05 | 196 | 20 | 3 | ad43efdd4d73b6615f65f06a315b33576e317473 | |
| ToppCell | 10x3'2.3-week_17-19|World / cell types per 3 fetal stages;per 3',per 5' | 8.92e-05 | 197 | 20 | 3 | f5cfad0b42d0f817e22cc78b9bfb2b4b7e4330ed | |
| ToppCell | COVID-19_Convalescent-Classical_Monocyte-cMono_2|COVID-19_Convalescent / Disease condition and Cell class | 9.06e-05 | 198 | 20 | 3 | f65fd9b773aeafa55e38309479954a8e41371f52 | |
| ToppCell | COVID-19_Severe-PLT_4|COVID-19_Severe / Disease Group and Platelet Clusters | 9.06e-05 | 198 | 20 | 3 | abfddbee99ef8c7719e6e6f62571e9be030e4acf | |
| ToppCell | LPS_only|World / Treatment groups by lineage, cell group, cell type | 9.19e-05 | 199 | 20 | 3 | 852cf595c2255983cff9045f2bb746d4391cf5ba | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_B-B_lineage-pre_B_progenitor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 9.19e-05 | 199 | 20 | 3 | dd94e42b62af7cbd69c472681d3c758552694ae2 | |
| ToppCell | COVID-19_Convalescent-Classical_Monocyte-cMono_2|Classical_Monocyte / Disease condition and Cell class | 9.19e-05 | 199 | 20 | 3 | 3feee9f53860b4b2e93ff2360beb2b2b74f51d24 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.33e-05 | 200 | 20 | 3 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 9.33e-05 | 200 | 20 | 3 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Slc17a6-Rora-Excitatory_Neuron.Slc17a6.Rora.Atp2b4_(Lateral_Geniculate_Nucleus_(LGN))|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.84e-04 | 45 | 20 | 2 | 0bb32882d2fbea4005700410b4de7f7a7058358e | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7.Syt6-Cyp26b1_(Deep_layer_pyramidal_cells)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.65e-04 | 54 | 20 | 2 | 2e177a9fd0f7c033dbcfa8b41b76658d8268644c | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7.Syt6-Cyp26b1_(Deep_layer_pyramidal_cells)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.65e-04 | 54 | 20 | 2 | 4daa84df51cc99113a9f8e86b1ae09bd76a9c991 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Bcl6-Excitatory_Neuron.Slc17a7.Bcl6-Npnt_(Layer_5a)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.85e-04 | 56 | 20 | 2 | 112a412816287423089c0333a42432a6ab4500dc | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Hematologic-red_blood_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.71e-04 | 86 | 20 | 2 | 1f44bb41835445aa60a2e3c31616c5847447a246 | |
| ToppCell | droplet-Heart-nan-18m-Hematologic-erythrocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.79e-04 | 104 | 20 | 2 | 060f0baca239ab89c18be40c1aa31931f4791b62 | |
| ToppCell | facs-Aorta-Heart-24m-Myeloid-professional_antigen_presenting_cell|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-03 | 118 | 20 | 2 | 171afacd54b2e447f9f8c4511e93ff4504cd47cc | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-8|TCGA-Lung / Sample_Type by Project: Shred V9 | 1.26e-03 | 118 | 20 | 2 | e3dca31f47324ee207b773145475147fe3e761fe | |
| ToppCell | (2)_unknow|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.32e-03 | 121 | 20 | 2 | 0090aef3d8a42968828edc637773ef99b2940dde | |
| ToppCell | (2)_Unknown|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.32e-03 | 121 | 20 | 2 | 6689c9016f29ce6a16824614b6229a71c42babb5 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Airway|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.39e-03 | 124 | 20 | 2 | a7b7d8b14d1218194da8fcf69b4780b6e9469332 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Nts|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.45e-03 | 127 | 20 | 2 | ace2944328529fa029ee56c7ad3b0f283511d3bb | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-Mes-Like-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.48e-03 | 128 | 20 | 2 | 2cf0384240a4a663869cf6b27d954236f6214a9a | |
| ToppCell | RA-12._Cytoplasmic_Cardiomyocyte_II|RA / Chamber and Cluster_Paper | 1.52e-03 | 130 | 20 | 2 | 314da0b9f24473e1f4e51e884c1768f23a95ba79 | |
| ToppCell | wk_08-11-Hematologic-Meg-ery-Definitive_erythrocyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.54e-03 | 131 | 20 | 2 | 537a79ea2b5d6b3dc0444570b1acbceda59b0d7c | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_B0|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.59e-03 | 133 | 20 | 2 | 386c9bbd9bab62209a67ebae6cd6ac0d7cef0a2d | |
| ToppCell | ILEUM-non-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.64e-03 | 135 | 20 | 2 | b7a792a7c0c22d8b703509f134115f0e394d7de0 | |
| ToppCell | PND07-28-samps-Lymphocyte-B_cell-B_cell_2|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.69e-03 | 137 | 20 | 2 | 2544d1256f11da6e3bad24a871b2253e0ab20d01 | |
| ToppCell | PND07-28-samps-Lymphocyte-B_cell|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.69e-03 | 137 | 20 | 2 | 874e2eaa7846a2832f46b77c726d79f220a4a1cd | |
| ToppCell | COVID-19-kidney-Technical/muscle|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.74e-03 | 139 | 20 | 2 | 13247bcb21c57c808657e0f543d6f134eeea7cc1 | |
| ToppCell | Mild/Remission-B_naive-13|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.81e-03 | 142 | 20 | 2 | 49873a2d9b1ae4bdbf253d1c09bf8845cc0cc917 | |
| ToppCell | 10x5'v1-week_12-13-Hematopoietic-erythroid-late_erythroid|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.86e-03 | 144 | 20 | 2 | ca365380ccf5e60d2e3f6272059ff0531759612d | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Bcl6|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.86e-03 | 144 | 20 | 2 | 08005be9e3367f78ef27e125d9cce5ca53f4bd2d | |
| ToppCell | Mild/Remission-B_naive-13|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.89e-03 | 145 | 20 | 2 | 7827aef87f834cd0d19780417757c9386e19b22e | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.94e-03 | 147 | 20 | 2 | 94998bc40f5c08295cfe3bdcbe43f13b1e564b3d | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.96e-03 | 148 | 20 | 2 | d6ac5972267254651dfbe16bb4e9a62228093cc7 | |
| ToppCell | facs-Limb_Muscle-Muscle_Diaphragm-18m-Endothelial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-03 | 150 | 20 | 2 | 96b160f163030fbf48aedc37d6ae224e11492c52 | |
| ToppCell | Healthy_donor-RBC|World / disease group, cell group and cell class (v2) | 2.02e-03 | 150 | 20 | 2 | 1e1a497ec4b048f7e9cc12dd5dd9aba7fedca9e1 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue | 2.04e-03 | 151 | 20 | 2 | 999c11d19b61d6b130ad5e623afa83cbdfe13cdd | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_EM-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.04e-03 | 151 | 20 | 2 | e1ffd99001b6a5b795f3367882a9355955c0e569 | |
| ToppCell | facs-Aorta-Heart-24m-Myeloid-nan|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.07e-03 | 152 | 20 | 2 | 525d65c5c8e5580947367afdb1f6e68b49e9e5bb | |
| ToppCell | Healthy_donor-RBC|Healthy_donor / disease group, cell group and cell class (v2) | 2.12e-03 | 154 | 20 | 2 | e080d5104fe6f3f6ef617bbcdccf1332ab7231e1 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_Invariant-Inducer-like-MAIT|Lung / Manually curated celltypes from each tissue | 2.15e-03 | 155 | 20 | 2 | 72c61be0a8d3ee10600a33c58fb01c35fd3f14d4 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 2.18e-03 | 156 | 20 | 2 | 1545169694f686d28648a68b552c2ae606599d66 | |
| ToppCell | Posterior_cortex|World / BrainAtlas - Mouse McCarroll V32 | 2.26e-03 | 159 | 20 | 2 | 18e9fe2efbe0bca7c3990f3b12b6f549e2c1263a | |
| ToppCell | Int-URO-Lymphocyte-B-Plasmablast|Int-URO / Disease, Lineage and Cell Type | 2.26e-03 | 159 | 20 | 2 | f6ad73b6a3681471efbd4fafd9eb631764c53500 | |
| ToppCell | facs-Trachea-nan-18m-Myeloid-lymphocyte_of_B_lineage|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-03 | 160 | 20 | 2 | 5c9281706009558c8361bfa76169f43ffc0f7947 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-03 | 160 | 20 | 2 | 56e6f4b82b5dc41c45f9d253c2db314a6f702b84 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-03 | 160 | 20 | 2 | bb1b966fb9e801db15e67d03e49db4609d6f935a | |
| ToppCell | Brain_organoid-organoid_Velasco_nature|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type. | 2.32e-03 | 161 | 20 | 2 | 2de213169fe1965ceaea545297228117c81d9909 | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|RV / Chamber and Cluster_Paper | 2.32e-03 | 161 | 20 | 2 | 47b3b7662cbb671ccc086dc0a0cabd65f63eb5a1 | |
| ToppCell | Mild-MAIT|Mild / Disease group and Cell class | 2.32e-03 | 161 | 20 | 2 | 0c1a04485708d5302600cdc2d7dac1cb76b4033a | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.32e-03 | 161 | 20 | 2 | ba7ce599b173cf81c8323e7c96dc3d57379f1ed6 | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-03 | 162 | 20 | 2 | 7e6d20704d77b28512690f882f9ddbbd9c5c3228 | |
| ToppCell | facs-Thymus-Thymus_Flowthrough|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-03 | 162 | 20 | 2 | 2c193f766f2cefe67682f34325d1de6aed778f49 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.37e-03 | 163 | 20 | 2 | 6bed27d2f67a430a847da5eb47878d14b4949c45 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs_st-18m-Lymphocytic-T_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.40e-03 | 164 | 20 | 2 | 1a9b444d2c6abcc83d4355ec5228b27541df2bd0 | |
| ToppCell | facs-Trachea-18m-Hematologic-lymphocytic-B_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.40e-03 | 164 | 20 | 2 | 4274a4f225cabf61f0fe27d8ea162b4eba612f87 | |
| ToppCell | facs-Trachea-18m-Hematologic-lymphocytic-B_cell-B_cell_of_the_trachea|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.40e-03 | 164 | 20 | 2 | d62143450f59097ad4b34603a6257f897a769ead | |
| ToppCell | facs-Marrow-B-cells-18m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.43e-03 | 165 | 20 | 2 | 361a605d8f833d9ec54b120480dce397da35f9c3 | |
| ToppCell | LPS-antiTNF-Endothelial-Mes-Like-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.46e-03 | 166 | 20 | 2 | 3b750d4023a0a09d86113aae5a97d84391f7b482 | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-NK_cell-NK|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.49e-03 | 167 | 20 | 2 | 42b299273a6c72a625b204d55f4f3c4eebd6d185 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.49e-03 | 167 | 20 | 2 | 3edb0570e583bb527165bcd8a4c25a042054043b | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-NK_cell|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.49e-03 | 167 | 20 | 2 | 94642b3dae035fedb6e8b9745f440096a4539f3c | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-mesothelial_cell-mesothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.49e-03 | 167 | 20 | 2 | 1adb566f98af0109c8cc6e36033b89651e2c75e7 | |
| ToppCell | Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 2.49e-03 | 167 | 20 | 2 | 9efb9511a211d0824bb97f82c1a5860c43d2138f | |
| ToppCell | Cerebellum-Neuronal-Inhibitory|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 2.49e-03 | 167 | 20 | 2 | 904c613aac3f9919a432b110bb1dcc832b5aec0a | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-mesothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.49e-03 | 167 | 20 | 2 | 743df5908c1ceb43b34b240d9f9649f30f4142fa | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-NK_cell-NK-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.49e-03 | 167 | 20 | 2 | ecf5bc634e1e01efd783617eb81d1704e903ea21 | |
| ToppCell | PND01-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.52e-03 | 168 | 20 | 2 | 55c9de7b3a1d6cf7b02b020ff92ab4ede8d195cc | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-hematologic-erythrocytic|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.52e-03 | 168 | 20 | 2 | 360cd756067c8cfb6a78301674758eb5fac52c23 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-neuro-epithelial-EC_cells_(NPW+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.52e-03 | 168 | 20 | 2 | 4e1b522c7400c9d87f63c00e4e1dd07136095cd6 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-hematologic-erythrocytic-erythrocyte|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.52e-03 | 168 | 20 | 2 | d791116040a9d3ea0485d68c974340116073986b | |
| ToppCell | 3'_v3-Lung-Lymphocytic_Invariant-Inducer-like|Lung / Manually curated celltypes from each tissue | 2.52e-03 | 168 | 20 | 2 | b9bde6f542d730682d34a80e1f7f1609e5c699c7 | |
| ToppCell | Mild/Remission-B_naive-4|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.55e-03 | 169 | 20 | 2 | c3a6179a64589a370108fea809b157839347759c | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)|Smart-seq2 / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.55e-03 | 169 | 20 | 2 | 0ee74cc97a2db9cc16dc73424f74747afe13af90 | |
| ToppCell | IIF|World / Disease, Lineage and Cell Type | 2.55e-03 | 169 | 20 | 2 | ebf726f725079317ad67c2f754748b4112607277 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.55e-03 | 169 | 20 | 2 | c5015ddb838849ea892a2cae5a739b554eb6d793 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-hematologic-erythrocytic-erythroid_lineage_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.58e-03 | 170 | 20 | 2 | 288014dedda8babc51fe08e48a55e68d83e1b1d2 | |
| ToppCell | Control-Myeloid-Mast|Control / Disease state, Lineage and Cell class | 2.58e-03 | 170 | 20 | 2 | 9a14deb7f7cd4a49c217eba4023f7bf1dec6c902 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-hematologic-hematopoietic_progenitor-erythroid_progenitor_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.58e-03 | 170 | 20 | 2 | 74bb46826141bd1e80b4ce16e6bbfc770bd427d3 | |
| Computational | Neighborhood of DDX5 | 5.26e-05 | 63 | 13 | 3 | GNF2_DDX5 | |
| Computational | Neighborhood of HDAC1 | 2.77e-04 | 110 | 13 | 3 | GNF2_HDAC1 | |
| Drug | CAS 298-57-7 | 4.53e-07 | 73 | 20 | 4 | CID000002761 | |
| Drug | Cinildipine | 1.56e-05 | 56 | 20 | 3 | CID000002752 | |
| Drug | nilvadipine | 1.92e-05 | 60 | 20 | 3 | CID000004494 | |
| Drug | NSC759576 | 2.09e-05 | 191 | 20 | 4 | CID000003075 | |
| Drug | lercanidipine | 2.23e-05 | 63 | 20 | 3 | CID000065866 | |
| Drug | mibefradil | 2.33e-05 | 64 | 20 | 3 | CID000060662 | |
| Drug | gallopamil | 2.68e-05 | 67 | 20 | 3 | CID000001234 | |
| Drug | AC1L2AC7 | 2.93e-05 | 69 | 20 | 3 | CID000068733 | |
| Drug | Barium | 3.33e-05 | 72 | 20 | 3 | ctd:D001464 | |
| Drug | ethosuximide | 3.61e-05 | 74 | 20 | 3 | CID000003291 | |
| Drug | dihydrocapsaicin | 4.01e-05 | 11 | 20 | 2 | CID000107982 | |
| Drug | nisoldipine | 4.23e-05 | 78 | 20 | 3 | CID000004499 | |
| Drug | AC1NUZ8M | 6.92e-05 | 92 | 20 | 3 | CID000073211 | |
| Drug | manidipine | 7.62e-05 | 95 | 20 | 3 | CID000004008 | |
| Drug | nitrendipine | 8.36e-05 | 98 | 20 | 3 | CID000004507 | |
| Drug | isradipine | 8.88e-05 | 100 | 20 | 3 | CID000003784 | |
| Drug | loperamide | 1.03e-04 | 105 | 20 | 3 | CID000003954 | |
| Drug | pyraclofos | 1.06e-04 | 106 | 20 | 3 | CID000093460 | |
| Drug | lamotrigine | 1.38e-04 | 116 | 20 | 3 | CID000003878 | |
| Drug | amiloride | 1.46e-04 | 315 | 20 | 4 | CID000016230 | |
| Drug | bepridil | 1.76e-04 | 126 | 20 | 3 | CID000002351 | |
| Drug | pimozide | 1.80e-04 | 127 | 20 | 3 | CID000016362 | |
| Drug | lanthanum | 2.21e-04 | 136 | 20 | 3 | CID000023926 | |
| Drug | isovalerate | 2.56e-04 | 143 | 20 | 3 | CID000010430 | |
| Drug | Dantrolene-13C3 | 2.66e-04 | 145 | 20 | 3 | CID000002951 | |
| Drug | nimodipine | 2.66e-04 | 145 | 20 | 3 | CID000004497 | |
| Drug | nicardipine | 2.66e-04 | 145 | 20 | 3 | CID000004473 | |
| Drug | Bay K 8644 | 2.94e-04 | 150 | 20 | 3 | CID000002303 | |
| Drug | valproate | 3.02e-04 | 381 | 20 | 4 | CID000003121 | |
| Drug | procaine | 3.12e-04 | 153 | 20 | 3 | CID000004914 | |
| Drug | cobalt-60 | 3.30e-04 | 390 | 20 | 4 | CID000061492 | |
| Drug | IHC-64 | 3.81e-04 | 33 | 20 | 2 | CID000162753 | |
| Drug | CNS 1145 | 3.81e-04 | 33 | 20 | 2 | CID000190902 | |
| Drug | felodipine | 4.17e-04 | 169 | 20 | 3 | CID000003333 | |
| Drug | gabapentin | 4.17e-04 | 169 | 20 | 3 | CID000003446 | |
| Drug | AC1NRA5C | 4.54e-04 | 174 | 20 | 3 | CID005287709 | |
| Drug | MnTMPyP | 5.33e-04 | 39 | 20 | 2 | CID000004233 | |
| Drug | zinc chloride (ZnCl2 | 5.52e-04 | 186 | 20 | 3 | CID000005727 | |
| Drug | Ethotoin [86-35-1]; Down 200; 19.6uM; PC3; HT_HG-U133A | 5.70e-04 | 188 | 20 | 3 | 4545_DN | |
| Drug | dihydropyridine | 6.15e-04 | 193 | 20 | 3 | CID000104822 | |
| Drug | Medrysone [2668-66-8]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 6.24e-04 | 194 | 20 | 3 | 4727_DN | |
| Drug | Diloxanide furoate [3736-81-0]; Up 200; 12.2uM; HL60; HT_HG-U133A | 6.52e-04 | 197 | 20 | 3 | 3062_UP | |
| Drug | Theophylline monohydrate [5967-84-0]; Down 200; 20.2uM; MCF7; HT_HG-U133A | 6.62e-04 | 198 | 20 | 3 | 3326_DN | |
| Drug | rofecoxib; Up 200; 10uM; MCF7; HG-U133A | 6.82e-04 | 200 | 20 | 3 | 251_UP | |
| Drug | phenytoin | 8.87e-04 | 219 | 20 | 3 | CID000001775 | |
| Drug | nickel | 1.22e-03 | 552 | 20 | 4 | CID000000934 | |
| Drug | IAA-94 | 1.30e-03 | 61 | 20 | 2 | CID000003667 | |
| Drug | AC1L1TJF | 1.52e-03 | 66 | 20 | 2 | CID000003377 | |
| Drug | tetraen | 1.52e-03 | 66 | 20 | 2 | CID000008197 | |
| Disease | childhood absence epilepsy (is_implicated_in) | 1.22e-05 | 8 | 20 | 2 | DOID:1825 (is_implicated_in) | |
| Disease | stomach cancer (is_marker_for) | 4.13e-03 | 142 | 20 | 2 | DOID:10534 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GELDSRYARRRYYRL | 201 | Q9UJX6 | |
| RYARRRYYRLLQSPL | 206 | Q9UJX6 | |
| GLVRDIRRRYPYYLS | 381 | P02730 | |
| FARLPPYRYRFRRRS | 221 | O60359 | |
| RSRRAPSFPYSYRYR | 6 | Q9UN42 | |
| SRDRRFRGRYRSPYS | 86 | Q14498 | |
| SAITRIPSYRYRYQR | 221 | Q9Y698 | |
| IPSYRYRYQRRSRSS | 226 | Q9Y698 | |
| TGRSSYYYRLLRRPR | 11 | Q5VWQ8 | |
| IYRASYYRRGDRALL | 671 | P29376 | |
| LTYRYFPRRRLQRGS | 111 | Q17RF5 | |
| LRRRYYTTPTSYLEL | 2656 | Q9C0G6 | |
| LARLATRTRRPSYYY | 181 | Q7Z601 | |
| TRTRRPSYYYLLALT | 186 | Q7Z601 | |
| RRPYYADYSPTRRSI | 1596 | O95180 | |
| SRSRYRGSRYSRSPY | 146 | Q9BRL6 | |
| RRYRERRYGFTRRYY | 91 | Q9BUV0 | |
| RRYGFTRRYYRSPSR | 96 | Q9BUV0 | |
| TRRYYRSPSRYRSRS | 101 | Q9BUV0 | |
| RRGYRRPYNYRRRPR | 326 | P16989 | |
| YRRRSPSPYYSRYRS | 256 | Q13595 | |
| YSRALYRRRRAPQPR | 126 | Q6PEY1 | |
| RSSPYRERTRYSRPY | 436 | Q9BYW2 | |
| RSPYLRATYRYTPLL | 66 | Q9H3S5 | |
| RDQIYRRRSPSPYYS | 256 | P62995 |